Drugs Made In America Acquisition Corp.

(NASDAQ) DMAA

Current Price$10.55

Market Cap$356.39M

Since IPO (2025)+6%

5 YearN/A

1 Year+5%

1 Month+1%

Drugs Made In America Acquisition Corp. Financials at a Glance

Market Cap

$356.39M

Revenue (TTM)

$0.00

Net Income (TTM)

$5.94M

EPS (TTM)

$0.18

P/E Ratio

59.65

Dividend

$0.00

Beta (Volatility)

-0.13 (Low)

Dividend

$0.00

Beta (Volatility)

-0.13 (Low)

Price

$10.55

Volume

Open

$10.55

Price

$10.55

Volume

Open

$10.55

Previous Close

$10.55

Daily Range

$10.55 - $10.55

52-Week Range

$10.07 - $10.57

Dividend

$0.00

Beta (Volatility)

-0.13 (Low)

Price

$10.55

Volume

Open

$10.55

Previous Close

$10.55

Daily Range

$10.55 - $10.55

52-Week Range

$10.07 - $10.57

DMAA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drugs Made In America Acquisition Corp.

Industry

Capital Markets

Sector

Financials

Employees

CEO

Lynn Darlene Stockwell

Website

www.dmaacorp.com

Headquarters

Fort Lauderdale, FL 33301, US

DMAA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-1%

Return on Assets

Earnings Yield

1.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$356.39M

Shares Outstanding

33.72M

Volume

Avg. Volume

154.26K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$2.82M

EBITDA

$2.82M

Operating Cash Flow

$539.19K

Capital Expenditure

$0.00

Free Cash Flow

$539.19K

Cash & ST Invst.

$6.14K

Total Debt

$0.00

Drugs Made In America Acquisition Corp. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$356.39M

N/A

Market Cap/Employee

$178.19M

N/A

Employees

N/A

Net Income

$212.96K

+76429.0%

EBITDA

$2.09M

N/A

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$6.14K

+791.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

2.48%

N/A

Return on Invested Capital

-1.18%

N/A

Free Cash Flow

$125.18K

-101670.7%

Operating Cash Flow

$125.18K

-101672.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TACHTitan Acquisition Corp.

TACHTitan Acquisition Corp.$10.33+0.19%

OYSEOyster Enterprises II Acquisition Corp

OYSEOyster Enterprises II Acquisition Corp$10.23+0.02%

SIMASIM Acquisition Corp. I

SIMASIM Acquisition Corp. I$10.77+0.50%

MLACMountain Lake Acquisition Corp.

MLACMountain Lake Acquisition Corp.$10.56+0.05%

TACOBerto Acquisition Corp.

TACOBerto Acquisition Corp.$10.34-0.10%

RTACRenatus Tactical Acquisition Corp I Class A Ordinary Shares

RTACRenatus Tactical Acquisition Corp I Class A Ordinary Shares$10.35-0.56%

ALFCenturion Acquisition Corp.

ALFCenturion Acquisition Corp.$10.87+0.55%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$9.14+2.95%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.35+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.11+0.00%

SOUNSoundHound AI

SOUNSoundHound AI$9.77+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$66.03+0.01%

ADTADT

ADTADT$7.14-0.05%

GMEGameStop

GMEGameStop$25.18-0.05%

Questions About DMAA

What is the current price of Drugs Made In America Acquisition Corp.?

Drugs Made In America Acquisition Corp. is trading at $10.55 per share.

What is the 52-week range for Drugs Made In America Acquisition Corp.?

Over the past 52 weeks, Drugs Made In America Acquisition Corp. has traded between $10.07 and $10.57.

How much debt does Drugs Made In America Acquisition Corp. have?

As of the most recent reporting period, Drugs Made In America Acquisition Corp. reported total debt of N/A.

How much cash does Drugs Made In America Acquisition Corp. have on hand?

Drugs Made In America Acquisition Corp. reported $6,137 in cash and cash equivalents in its most recent financial results.

What is Drugs Made In America Acquisition Corp.’s dividend yield?

Drugs Made In America Acquisition Corp. does not currently have a dividend yield.

Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. Financials at a Glance

DMAA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Drugs Made In America Acquisition Corp.

DMAA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Drugs Made In America Acquisition Corp. Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DMAA

What is the current price of Drugs Made In America Acquisition Corp.?

What is the 52-week range for Drugs Made In America Acquisition Corp.?

How much debt does Drugs Made In America Acquisition Corp. have?

How much cash does Drugs Made In America Acquisition Corp. have on hand?

What is Drugs Made In America Acquisition Corp.’s dividend yield?

Premium Investing Services